Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma

Abstract

Optimal approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma. Recommendations are provided.

Keywords

• targeted therapy
• patients
• metastatic renal carcinoma
• progression
• treatment
• pazopanib